Ionis Pharmaceuticals (IONS): EVP CLO & General Counsel sold ~$39K
Patrick R. O'neil, EVP CLO & General Counsel at Ionis Pharmaceuticals, sold ~$39K of Ionis Pharmaceuticals shares.
- ~$39K
- Approx. value · 1,207 sh @ $32.35
- 56K
- Holds after · shares reported
- Traded
- Feb 20, 2025
- Filed
- Feb 24, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 23, 2024Insider · 1 personInsiders: 2 purchases (~$181K)
- Jan 16, 2025Insider · 10 peopleInsiders: 12 sales (~$3.0M)
- Jan 31, 2025Insider · 7 peopleInsiders: 7 sales (~$705K)
- Feb 4, 2025Insider · 2 peopleInsiders: 2 sales (~$1.4M)
- Feb 20, 2025 · this disclosureInsiderOfficer sold ~$39K of IONS shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Ionis Pharmaceuticals
For Ionis Pharmaceuticals, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IONS page.
Other recent filings by Patrick R. O'neil, EVP CLO & General Counsel
- SEC Form 4 at Ionis Pharmaceuticals (IONS)Sep 16, 2025
- SEC Form 4 at Ionis Pharmaceuticals (IONS)Sep 11, 2025
- SEC Form 4 at Ionis Pharmaceuticals (IONS)Sep 11, 2025
- SEC Form 4 at Ionis Pharmaceuticals (IONS)Sep 5, 2025
- SEC Form 4 at Ionis Pharmaceuticals (IONS)Sep 5, 2025
The full history of Patrick R. O'neil, EVP CLO & General Counsel is on the profile page.
How this filing works
Explore the data
Other disclosures at Ionis Pharmaceuticals
- SEC Form 4Nov 13, 2026
- SEC Form 13F-HRNov 13, 2026
- SEC Form 4Oct 20, 2026
- SEC Form 4Oct 20, 2026
- SEC Form 144Oct 16, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its IONS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data